DTaP vaccine - Serum Institute of India
Alternative Names: Acellular pertusis vaccines - Serum Institute of India; Diphtheria tetanus-acellular pertussis vaccine - Serum Institute of IndiaLatest Information Update: 09 Mar 2021
At a glance
- Originator Serum Institute of India
 - Class Bacterial vaccines
 - Mechanism of Action Immunostimulants
 
- 
          
            
              Orphan Drug Status
              No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
 - New Molecular Entity No
 
Highest Development Phases
- Phase II/III Diphtheria; Pertussis; Tetanus
 
Most Recent Events
- 09 Mar 2021 Phase-II/III development is ongoing for Tetanus, Pertussi and Diphtheria (In adolescents, In adults, In children, Prevention) (CTRI/2018/06/014617)
 - 03 Nov 2020 GenKyoTex has been acquired by Calliditas Therapeutics
 - 02 Jul 2018 Phase-II/III clinical trials in Diphtheria (Prevention, In adults, In adolescents, In children) in India (IM) (CTRI2018-06-014617)